show episodes
 
Artwork

1
Business Of Biotech

Matt Pillar

Unsubscribe
Unsubscribe
Еженедельно
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
  continue reading
 
Artwork

1
BioBoss

John Simboli

Unsubscribe
Unsubscribe
Ежемесячно
 
BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.
  continue reading
 
Artwork

1
The Syneos Health Podcast

Jeffrey Stewart

Unsubscribe
Unsubscribe
Ежемесячно
 
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Hosted by Jeff Stewart, a long-time industry consultant who has advised biopharma leaders on licensing, mergers and acquisitions, pricing and market access, commercialization and go-to-market strategies, each episode explores the challenges and considerations involved wi ...
  continue reading
 
Artwork

1
The AI Podcast

NVIDIA

Unsubscribe
Unsubscribe
Ежемесячно+
 
One person, one interview, one story. Join us as we explore the impact of AI on our world, one amazing person at a time -- from the wildlife biologist tracking endangered rhinos across the savannah here on Earth to astrophysicists analyzing 10 billion-year-old starlight in distant galaxies to the Walmart data scientist grappling with the hundreds of millions of parameters lurking in the retailer’s supply chain. Every two weeks, we’ll bring you another tale, another 25-minute interview, as we ...
  continue reading
 
Pharmacokinetic and Biopharmaceutics from the University of Oklahoma College of Pharmacy - PDF files of course material, Audio AND Video tutorials PHAR 7633 - Description and quantitation of factors affecting the absorption, distribution, and metabolism, and excretion of drugs. Development of appropriate dosage regimens and graphical analysis of drug concentration data sets. Bioequivalence and drug product testing. Drug analysis in biological matrix.
  continue reading
 
Artwork

1
ASA Biopharm's Podcast

American Statistical Association (ASA) Biopharm. Section

Unsubscribe
Unsubscribe
Ежемесячно
 
In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.
  continue reading
 
Artwork

1
Inside Biotech

Ananta Wadhwa, Kathy Grotsch PhD, Gabriella Rubert, Leo Ying

Unsubscribe
Unsubscribe
Ежемесячно
 
Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside ...
  continue reading
 
Artwork

1
Stock Day Media

Stock Day Media

Unsubscribe
Unsubscribe
Ежедневно
 
Stock Day Media is the top source for Penny and Micro-Cap news in America. Our Mission is to provide transparency to publicly traded companies and inform the investors directly. Our reach in the stock market community gives Stock Day the ability to find new potential investors that are seeking unique and lucrative opportunities.
  continue reading
 
Loading …
show series
 
We love to hear from our listeners. Send us a message. Allan Shaw is back with us this week to dig into the complexities of strategic hiring in biotech. We cover strategies for the step-wise assembly of effective executive teams, the importance of aligning key hires with clinical and regulatory milestones, managing salaries in line with cash runway…
  continue reading
 
As the global population approaches 10 billion by 2050, the challenge of providing safe, nutritious food is growing more urgent. Climate change is further straining food systems, impacting water availability, crop yields, and livestock health. In this episode, two experts discuss innovative biotech solutions aimed at addressing these pressing issue…
  continue reading
 
We love to hear from our listeners. Send us a message. Mike Kelly faced a self-reckoning before he took the job as CEO at NervGen, a company developing peptide therapeutics targeted specifically at central nervous system repair. The veteran of life sciences business development knew the ropes of the biotech C-suite. He’d been a CEO twice before. He…
  continue reading
 
In this insightful episode of Driving Digital in Biopharma, host Tom Lehmann explores with Áine Hanly, Chief Technology Officer at Vir Biotechnology, the transformative role of data and technology in drug development and manufacturing. Áine delves into the advancements in data accessibility and automation, such as single-cell manipulation and high …
  continue reading
 
Send us a text 256 - Paul Levy is a renowned author and thought leader. His books focus on Wetiko, the virus plaguing the individual and collective mind. Topic discussions include: -The origins of Wetiko and manifestations of it in our culture -How our system feeds and perpetuates Wetiko -Stepping into darkness to confront our shadow -Spiritual war…
  continue reading
 
From improving energy efficiency to helping address climate challenges, AI and accelerated computing are becoming key tools in the push for sustainability. In this episode of NVIDIA’s AI Podcast, Joshua Parker, senior director of corporate sustainability, shared his perspective on how these technologies are contributing to a more sustainable future…
  continue reading
 
Use of circulating tumor DNA (ctDNA) – small fragments of DNA that are released into the bloodstream by cancer cells – as a diagnostic tool represents a significant shift toward more precise, personalized cancer care, enhancing both trial efficiency and patient experience. Unlike traditional tissue biopsies, which sample a single tumor site, ctDNA …
  continue reading
 
We love to hear from our listeners. Send us a message. It wouldn't be accurate to say that surgeon-turned-healthcare investment banker and consultant Dr. Ali Pashazadeh traded his scalpels for spreadsheets. In fact, he still wields a scalpel quite frequently, and on this episode of the Business of Biotech podcast, he offers a fantastic reason why. …
  continue reading
 
Send us a text 255 - This is the dawn of a new era, one in which the heart takes center stage. Will you have the courage to break down your walls and embrace vulnerability? It's time to let go and let love in. Topics include: -The myth of Eros -Love's shadow side -The delicate balance between letting go and holding on -Embracing vulnerability over …
  continue reading
 
Companies in the US spend $15bn annually on talent acquisition. The most important metric in recruitment advertising is the conversion from the paid click on the job platform to the application the employer receives. Industry-wide, apply conversion is just 5%. Redirection of the candidate from the job platform to the company site is the biggest cau…
  continue reading
 
Medical science liaisons—or MSLs—within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering. Only they can share certain types of information with a growing number of medical stakeholders. And only they can bring back medical insights to guide strategic development and brand decisions. Yet, can…
  continue reading
 
Since Watson and Crick discovered DNA's double helix structure in 1953, the US has been a leader in biotechnology innovation. American excellence in this field has greatly benefited people around the world. In this episode, we talk about why this leadership position may be threatened and why that matters to our national security. Follow us on Linke…
  continue reading
 
We love to hear from our listeners. Send us a message. Hilary Eaton, Ph.D. was a self-described AI skeptic, particularly as it relates to using the tool in drug discovery. Then, a series of professional and deeply personal life events and medical discoveries put her in a position to confront that skepticism head-on. Today, she's Chief Business Offi…
  continue reading
 
Send us a text 254 - Libby Androusky joins the podcast live in-studio. This wide-ranging discussion attempts to make sense of life as a soul in the potential end times. Topic discussions include: -Bringing order out of chaos -Mankind's cyclical nature repeated throughout history -Are we heading towards Armageddon? -Hope is not enough to bring chang…
  continue reading
 
Send us a text 253 - Julie Dean Richards, also known as the Crunchy Legal Lady, is bridging the gap between holistic health and law. Her legal work revolves around simplifying the law for holistic families. Topic discussions include: -Understanding our fundamental rights -Censorship and the attack on civil liberties -Bridging the gap between law, h…
  continue reading
 
In this episode of Inside Biotech, we explore the transition from academia to product management with Dr. Sara Tafoya, Global Product Manager at Sony Biotechnology. Sara’s passion lies in helping STEM graduate students and early career professionals recognize the value of their technical expertise beyond the bench. She shares her journey from PhD t…
  continue reading
 
We love to hear from our listeners. Send us a message. SR One Capital Management CEO Simeon George, M.D. has a seemingly innate ability to pick winning biotech builders. Early on, he and his firm got behind CRISPR's Samarth Kulkarni, Ph.D., Arcellx' Rami Elghandour, and Nkarta's Paul Hastings, for example. With nearly 50 biotech leaders in SR One's…
  continue reading
 
This episode of Driving Digital in Biopharma offers a peek into the digital revolution brewing in the biopharma labs, courtesy of Richard Milne, the Vice-president and general manager of Digital Science Solutions at Thermo Fisher Scientific. From e-commerce roots to pioneering digital science, Richard and Tom delve into the vision for laboratories,…
  continue reading
 
This episode highlights different learning techniques for neurodivergent and neurotypical learners alike. In the episode, I discuss learning styles, creating an effective learning and study environment, taking good notes, time management techniques, learning aids, exam techniques, presentation advice, a study schedule, and how to write a thesis. Th…
  continue reading
 
David Fajgenbaum was in his third year of medical school when he was diagnosed with a rare and life-threatening disease that began shutting down his organs, bringing him perilously close to death. Although he survived the initial episode, he faced four additional relapses, each pushing him to the brink of death. In this episode, we speak with David…
  continue reading
 
Send us a text 252 - Letao Wang is a professional astrologist, tarot specialist, and the founder and spiritual counselor of the Healing Kingdom. He has been providing astrology, tarot, and numerology readings for clients both locally in Hong Kong and overseas since 2015. Letao joins the podcast for an epic conversation on all things tarot, self-dis…
  continue reading
 
We love to hear from our listeners. Send us a message. Erik van den Berg is CEO and board member at Memo Therapeutics, and he's a student of biotech chaos. In fact, he's been embracing it with intention for the past 30 years. On this episode of the Business of Biotech, he walks us through the management of that chaos in specific detail. Navigating …
  continue reading
 
Edward Mehr works where AI meets the anvil. The company he cofounded, Machina Labs, blends the latest advancements in robotics and AI to form metal into countless shapes for use in defense, aerospace, and more. The company’s applications accelerate design and innovation, enabling rapid iteration and production in days instead of the months required…
  continue reading
 
We love to hear from our listeners. Send us a message. This week, it’s another “Business of Biotech-meets-Business-of-RNA” takeover with Circio CEO Erik Digman Wiklund, Ph.D. and guest co-host Anna Rose Welch of Advancing RNA. While Circio’s legacy is in cancer immunology (it still boasts a cancer vaccine candidate targeting KRAS driver mutations),…
  continue reading
 
Send us a text 251 - Dr. Peter McCullough is a world-renowned cardiologist and a leading voice in the health freedom movement. Topic discussions include: -COVID-19 vaccine impacts nearly four years since the shot's rollout -The origins and intricacies of the biopharmaceutical complex -Election season and lack of political integrity over COVID-19 po…
  continue reading
 
We love to hear from our listeners. Send us a message. Guest co-host Anna Rose Welch of Advancing RNA fame joins us on this week’s Business of Biotech podcast for a conversation with the leaders of RNA upstart Radar Therapeutics. The company’s co-founders, Eerik Kaseniit, Ph.D. (CSO & President) and Sophia Lugo (CEO), are making waves in the mRNA t…
  continue reading
 
Send us a text 250 - Look up at the night sky. What do you see? Can you remember the stars are a reflection of you and me? Anthony Schneider and Marco Castillo join the podcast live in the studio with a message to look up! Full topic discussions: -Spiritual awakening and self-discovery -CE5 contact and extraterrestrial encounters -Moving beyond con…
  continue reading
 
Send us a text 249 - Jason Christoff is a world-renowned health & self-sabotage expert. He rejoins the podcast for a fifth time to discuss the foundational principles of health and invisible influence of mind control on our society. Full topic discussions include: -Taking control of your health to beat mind control -The war on Western Culture throu…
  continue reading
 
AI is seemingly everywhere now in our lives, including healthcare and drug discovery and development. AI certainly has the potential to enable major advances than development of more effective and safe medical products. And in fact, GenAI has already been successfully used in drug discovery. But are we fully leveraging the current AI yet in practic…
  continue reading
 
Snowflake is using AI to help enterprises transform data into insights and applications. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz and Baris Gultekin, head of AI at Snowflake, discuss how the company’s AI Data Cloud platform enables customers to access and manage data at scale. By separating the storage of data from compute, Snowfla…
  continue reading
 
Send us a text 248 - The hardest chains to break are the ones you defend having. Enter the dark place and illuminate it with the light of self-reflection. Full topic discussions: -Death and letting go -The spectrum of love and grief -Reconnecting with your inner child -The societal destruction of innocence -Embracing your hardship and the self-actu…
  continue reading
 
We love to hear from our listeners. Send us a message. For all the drug commercialization successes he's played a leading hand in during his tenures at GSK, Genentech, and ImClone—Androderm, Augmentin, necitumumab, and Erbitux among them—Michael Bailey concedes that he's likely better known for his failures. After hearing his stories on this episod…
  continue reading
 
We love to hear from our listeners. Send us a message. He's been a big pharma executive. He's a multi-time biotech founder and current biotech CEO. He was once a regulator. He's a physician. He serves on multiple boards. And as of this summer, he's president of one of the most influential global organizations dedicated to the advance of cell and ge…
  continue reading
 
Send us a text 247 - My brother, Anthony Schneider, returns to the podcast as our first live guest in Evan's return to South Dakota. It is good to be home. Topic discussions include: -The hero's journey through life -Death, grief, and heartbreak -Close encounters and higher dimensional beings -The path of truth and enlightenment Connect with Evan: …
  continue reading
 
Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Recursion, about how the company uses AI and machine learning to accelera…
  continue reading
 
The gut microbiome, which consists of trillions of bacteria, viruses, and fungi, plays a crucial role in our health. However, there is still much to learn about this complex ecosystem. On this episode we talk with experts who tell us where the science is—how much we know, and how much we don’t. Two companies, Bloom Science and Seres Therapeutics, a…
  continue reading
 
We love to hear from our listeners. Send us a message. Kristin Yarema, Ph.D. thinks the progress of CAR T therapeutics is allogeneic. In fact, she says CAR T-cell therapies have to become a one-to-many proposition, if their early autologous success can possibly live up to the promise of offering widespread accessibility to life-saving treatments. D…
  continue reading
 
We love to hear from our listeners. Send us a message. Flagship Pioneering’s ProFound Therapeutics is on to something, and it could be something big. It began with a simple question: What if more RNAs were being translated into proteins? Answering that question took ProFound deep into the translatome, where it’s now studying the full compendium of …
  continue reading
 
2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocate…
  continue reading
 
AI is set to transform the workforce — and the Georgia Institute of Technology’s new AI Makerspace is helping tens of thousands of students get ahead of the curve. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Arijit Raychowdhury, a professor and Steve W. Cedex school chair of electrical engineering at Georgia Tech’s college…
  continue reading
 
We love to hear from our listeners. Send us a message. While organic chemistry lectures caused many of his peers at NYU to wring their hands, gnash their teeth, and question life choices, then-19-year-old Enrique Diloné ate those classes for lunch. They inspired him to earn a Seton Hall Ph.D. in chemistry, and to go to work as a big bio research sc…
  continue reading
 
In this episode of the Stock Day Media Podcast, host interviews Josh Sodiatis, CEO of Peer to Peer Network (Mobi Card). Josh announces two major updates: the company's approval for crowdfunding via a FINRA-registered intermediary, allowing unaccredited investors to invest as little as $250, and a legal opinion ruling Mobi Coin as a utility token. H…
  continue reading
 
Loading …

Краткое руководство